Edetic Acid

Edetic Acid

SCHEMBL41639

O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Ca+2].[Na+].[Na+]

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Edetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.73
ALOX15 P16050 2/20 0.73
MAPT P10636 1/20 0.73
SMN1; SMN2 Q16637 1/20 0.73
TDP1 Q9NUW8 2/20 0.48
EYA2 O00167 1/20 0.48
APP P05067 1/20 0.48
ACE P12821 1/20 0.48
BLM P54132 2/20 0.46
PMP22 Q01453 2/20 0.46
LMNA P02545 1/20 0.46
CHRM2 P08172 1/20 0.46
ADRA2A P08913 1/20 0.46
TSHR P16473 1/20 0.46
DRD1 P21728 1/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46
CYP2C19 P33261 1/20 0.46
ADRA1A P35348 1/20 0.46
DRD3 P35462 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Edetic Acid SCHEMBL16004809 1.00 KDM4E (0.73) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL5485760 1.00 KDM4E (0.73) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL21043562 0.97 KDM4E (0.70) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL17747958 0.97 KDM4E (0.70) KDM4EALOX15MAPTSMN1; SMN2TDP1
Pentetic Acid SCHEMBL136882 0.97 KDM4E (0.77) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL2170101 0.97 KDM4E (0.70) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL906 0.97 KDM4E (0.76) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL44287 0.97 KDM4E (0.76) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL3835316 0.97 KDM4E (0.76) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL42427 0.97 KDM4E (0.76) KDM4EALOX15MAPTSMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 15787 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260146355-A1 \"Golden\" - Gold Nanomaterials AG-NANO SYSTEM LLC (US) 2026-05-28 US claimed
EP-4743067-A1 PHARMACEUTICAL FORMULATIONS FOR INHALATION AND USES THEREOF Insilico Medicine IP Limited (HK) 2026-05-20 EP claimed
EP-4734772-A1 EXTRUSION-ENCAPSULATED CALCIUM SALTS AS OPACIFYING/WHITENING AGENTS Capol Inc. (CA) 2026-05-06 EP claimed
WO-2026090627-A1 STABLE PITOLISANT LIQUID FORMULATIONS AND METHOD OF ITS USE PATEL SANDIPKUMAR (US) 2026-04-30 WO claimed
EP-4732829-A1 GLP-1-FC-FGF21 DOUBLE-TARGET FUSION PROTEIN COMPOSITION, AND INJECTION AND USE THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2026-04-29 EP claimed
US-12611531-B2 Coated microneedle with multilayer structure, method for preparing the same and microneedle patch comprising coated microneedle Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences (CN) 2026-04-28 US claimed
EP-3892114-B1 EFFERVESCENT BEVERAGE HAVING IMPROVED TASTE QUALITIES OF SUGAR AND SWEETENER SUNTORY HOLDINGS LTD (JP) 2026-04-22 EP claimed
EP-4719070-A1 METHOD OF PREPARING IMPROVED PASTA FILATA CHEESE AND SAID PASTA FILATA CHEESE Arla Foods amba (DK) 2026-04-08 EP claimed
US-20260076872-A1 POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME SIO2 MEDICAL PRODUCTS LLC (US) 2026-03-19 US claimed
EP-4260844-B1 OPHTHALMOLOGICAL COMPOSITIONS COMPRISING POLOXAMER LIEGNER JEFFERY T (US) 2026-03-18 EP claimed
US-4734222-A Composition and method for cleaning soft and hard contact lenses CIBA-GEIGY CORPORATION (US) 1988-03-29 US claimed
CN-86106616-A Dertergent for washing away pollutant from heavy metals 1987-04-22 CN claimed
EP-0208519-A2 Solubilized composition of hardly-soluble pharmaceutical product Takeda Chemical Industries, Ltd. (JP) 1987-01-14 EP claimed
EP-0184942-A2 Improved pharmaceutical composition containing 13-CIS vitamin a acid as the active ingredient ORTHO PHARMACEUTICAL CORPORATION (US) 1986-06-18 EP claimed
EP-0154009-A1 Use of a thiazide diuretic for the manufacture of a non-diuretic antihypertensive medicament Euro-Celtique S.A. (LU) 1985-09-11 EP claimed
EP-0028813-B1 STABLE SOLUTIONS OF HYDROGENATED ERGOTALCALOIDS OR THEIR SALTS AND HEPARIN OR ITS SALTS,AND PROCESS FOR THEIR PREPARATIONS SANDOZ AG (CH) 1984-07-25 EP claimed
EP-0023161-B1 PROCESS FOR THE MODIFICATION OF THE PHYSICAL AND BIOCHEMICAL CHARACTERISTICS OF ANIMAL BLOOD AFTER SLAUGHTERING, DEVICE FOR THE APPLICATION OF THE PROCESS, INDUSTRIAL PRODUCTS OBTAINED AND DERIVED APPLICATIONS Balsse, Christian (FR) 1983-07-13 EP claimed
US-4299853-A Biological preservation of beer Schoorlemmer, Ben 1981-11-10 US claimed
US-4195084-A Taste-stable aqueous pharmaceutical suspension of tall oil sitosterols and a method for the preparation thereof ELI LILLY AND COMPANY (US) 1980-03-25 US claimed
US-4107331-A Zinc chelating fungicidal composition ROSENBERG MAX 1978-08-15 US claimed